Search Results for 'Imatinib-Ears'

Imatinib-Ears published presentations and documents on DocSlides.

Imatinib  Resistance Geoffrey L. Uy, M.D.
Imatinib Resistance Geoffrey L. Uy, M.D.
by karlyn-bohler
Associate Professor . of Medicine. Division of On...
Imatinib
Imatinib
by phoebe-click
Resistance. Geoffrey L. Uy, M.D.. Associate Prof...
Impact of Imatinib interruption & duration of prior Hyd
Impact of Imatinib interruption & duration of prior Hyd
by pamella-moone
Raafat. R. Abdel-. Malek. , MD, FRCR. Ass. Prof ...
Treatment of  Imatinib -resistant GIST
Treatment of Imatinib -resistant GIST
by beatrice
: . The Next Generation. Dr. Michael Heinrich, M....
SCIENTIFIC DISCUSSION  1 Introduction The scope of this Type II varia
SCIENTIFIC DISCUSSION 1 Introduction The scope of this Type II varia
by evelyn
Metastasis of DFSP is rare, occurring in approxima...
Overview of CML & Recent Advances
Overview of CML & Recent Advances
by stella
I. ntroduction. CML is a clonal myeloproliferative...
GREETING  BUENOS DÍAS GOOD MORNING
GREETING BUENOS DÍAS GOOD MORNING
by escapistlego
BONJOUR. Tolerance of . Imatinib. . Dasatinib. ...
ADVANCES IN THERAPY FOR SARCOMA AND GIST
ADVANCES IN THERAPY FOR SARCOMA AND GIST
by ellena-manuel
Angela . Cioffi. , MD. Sarcoma Research Program c...
Modeling Imatinib-Treated Chronic Myeloid Leukemia
Modeling Imatinib-Treated Chronic Myeloid Leukemia
by phoebe-click
Cara Peters. cpeters3@math.umd.edu. Advisor: Dr. ...
Gastrointestinal Stromal Tumors
Gastrointestinal Stromal Tumors
by tawny-fly
Definition of Gastrointestinal Stromal Tumor . th...
ETV1 is a lineage survival factor that cooperates with KIT
ETV1 is a lineage survival factor that cooperates with KIT
by test
stromal. tumors. Introduction. Tim Butler. March...
Proceedings of UCLA HealthVOLUME 22201CLINICAL VIGNETTE
Proceedings of UCLA HealthVOLUME 22201CLINICAL VIGNETTE
by tracy
Dermatofibrosarcoma protuberans Fukai Leo Chuang, ...
La LAL del adulto tiene mal pronóstico
La LAL del adulto tiene mal pronóstico
by walsh
PETHEMA LAL infantil. PETHEMA LAL Adulto. 15%. 25%...
Chronic  M yeloid Leukemia
Chronic M yeloid Leukemia
by eliza
Amer Rassam, M.D.. Learning Objectives. Myeloproli...
Jon Trent, MD, PhD Professor of Medicine
Jon Trent, MD, PhD Professor of Medicine
by jane-oiler
Sarcoma . Medical Oncology. The University of . M...
Prof Giovanni  Brandi
Prof Giovanni Brandi
by liane-varnes
. University. of Bologna . Advances. in . c...
Chronic
Chronic
by briana-ranney
M. yeloid Leukemia. Amer Rassam, M.D.. Learning O...
OHSU Updates in Hematology
OHSU Updates in Hematology
by calandra-battersby
and. Breast Cancer Conference. CML . ASH Update. ...
Clinical Considerations in
Clinical Considerations in
by faustina-dinatale
Evidence-based Management . of GIST. Program Goal...
Anticancer Therapy:
Anticancer Therapy:
by stefany-barnette
Kinase. Inhibitors. Charles Harrell. Outline of ...
Philadephia
Philadephia
by danika-pritchard
chromosomal positive acute lymphoblastic leukemi...